NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Resilience

Resilience

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://resilience.com/

Last Round

Debt

Oct 29, 2025

Est. Valuation

$650M

Total Funding Raised

$2.68B

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Resilience is a biopharmaceutical manufacturing company that provides end-to-end manufacturing solutions for biologics, vaccines, and cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Drug Discovery, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

contract development and manufacturing organizationCDMObiomanufacturingbiologics manufacturingcell and gene therapyviral vector productionsterile manufacturingbiotech manufacturingdrug substance productionvaccine manufacturingprocess developmentpharma supply chaindigital twinsbiotech outsourcingdrug manufacturing scale-up

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resilience Comparables

Compare Resilience with similar companies based on industry and business-model similarity.

Resilience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ElevateBio
82%
WuXi Biologics
82%
Lonza Group
80%

Resilience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtOct 29, 2025
VC RoundJun 9, 2025
GrantOct 3, 2024
Series DAug 7, 2023
DebtMar 28, 2023
Private Equity
Jan 10, 2023

Key People

Founding team and executive leadership

ramadan youseef

Co-Chief Executive Officer

Executive Team

William S. Marth

President Chief Executive Officer

Executive Team

Andrew Montone

Chief Financial Officer

Executive Team

Resilience Investors

Notable investors and investment history

Resilience investors
InvestorRounds
Intact Private CapitalSeries C, Series D
Administration for Strategic Preparedness and ResponseGrant
GVSeries B
New Enterprise Associates (NEA)Series B
UL VenturesSeries B
Intact VenturesSeries C, Series D
ARCH Venture PartnersSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 43% MoM, reaching 25.2K.

  • Apr 4, 2026

    New commercial site in Blue Ash, Ohio, for IDAP operations.

Resilience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Resilience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Resilience's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range1,299
Year Founded2020
Last FundingOct 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.